• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHOU Wuliu,HU Xinyi,WU Feihua,JIN Jing.The mechanism of action of Shuimudizhuo Decoction in the treatment of polycystic ovary syndrome[J].Journal Of Pharmaceutical Research,2026,45(9):967-974[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 233times   Download 215次 QR Code for this article
Scan with your phone!
水木涤浊饮治疗多囊卵巢综合征作用机制
周武柳1,胡馨一2,吴斐华1,金晶3
Font:Larger+|Default|Smaller-
(1.中国药科大学,江苏 南京 211198;2.南京医科大学,江苏 南京 211100;3.南京中医药大学附属医院,江苏 南京 210029)
摘要:
目的 研究水木涤浊饮(SMDZ)对脱氢表雄酮(dehydroepiandrosterone,DHEA)诱导小鼠多囊卵巢综合征(PCOS)的治疗作用及其潜在机制。方法>/b> 将50只SPF级雌性C57BL/6小鼠随机分为正常对照组、模型组、水木涤浊饮低、高剂量组和单纯给药组。连续21 d皮下注射DHEA建立PCOS模型,再灌胃水木涤浊饮21 d后检测小鼠动情周期、卵泡种类和激素水平,通过网络药理学筛选作用靶点,构建PCOS细胞模型验证靶点。结果 与模型组相比,水木涤浊饮高剂量组可纠正动情周期紊乱、卵泡发育异常、激素水平异常(均P<0.05)。经网络药理学分析和细胞实验验证,水木涤浊饮可增强P53通路中MDM2、CCND1、BCL2L1蛋白表达,从而抑制CASP8、CASP9、CDKN1A表达水平(均P<0.05),逆转颗粒细胞凋亡。结论 水木涤浊饮通过调控p53信号通路逆转颗粒细胞凋亡,改善PCOS。
关键词:  多囊卵巢综合征  水木涤浊饮  网络药理学
DOI:10.13506/j.cnki.jpr.2026.09.002
基金项目:中华中医药学会青年培养计划项目(No.202403-002);江苏省高层次人才培养计划(“333”工程);江苏省中医院高峰学术人才培养项目(No.k2026yrc57)
Received Date:February 26, 2026   Revision Date:April 02, 2026   Publication Date:September 30, 2026
The mechanism of action of Shuimudizhuo Decoction in the treatment of polycystic ovary syndrome
ZHOU Wuliu1,HU Xinyi2,WU Feihua1,JIN Jing3
(1.China Pharmaceutical University,Nanjing 211198,China;2.Nanjing Medical University,Nanjing 211100,China;3.Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210000,China)
Abstract:
Objective>/b> To investigate the therapeutic effect of Shuimudizhuo Decoction on dehydroepiandrosterone (DHEA)-induced polycystic ovary syndrome(PCOS) mice and its potential mechanism. Methods Fifty SPF-grade female C57BL/6 mice were randomly divided into a blank control group, a model group, low-dose and high-dose groups of Shuimudizhuo Decoction, and drug-only group. The PCOS model was established by subcutaneous injection of DHEA for 21 days. After 21 days of gavage of Shuimudizhuo Decoction, the estrous cycle, types of follicles, ovarian histology and hormone levels of mice were analyzed. Target screening was performed through network pharmacology and verified in vitro. Results Compared with the model group, the high-dose group of Shuimudizhuo Decoction could correct estrous cycle disorders, abnormal follicular development, and abnormal hormone levels (all P<0.05). Through network pharmacological analysis and in vitro experiments, it has been verified that Shuimudizhuo Decoction may reverse granulosa cell apoptosis by enhancing the expression of MDM2、CCND1、BCL2L1 proteins, inhibiting the expression of CASP8, CASP9, and CDKN1A proteins, and enhancing the expression of CCND1 protein (all P<0.05). Conclusion Shuimudizhuo Decoction reverses granulosa cell apoptosis and improves PCOS by regulating the p53 signaling pathway.
Key words:  Polycystic Ovary syndrome  Shuimudizhuo Decoction  Network pharmacology
Today's Visits:447    Total Visits:2383131
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.